Status:
RECRUITING
The Bern Rehab Registry
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Cancer
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study examines the health outcomes of patients with long-term illnesses such as cancer, heart, lung, or musculoskeletal diseases who participate in a rehabilitation programme. The programme may i...
Detailed Description
Background: The global demographic landscape is shifting towards an aging population, coupled with a rise in chronic, non-communicable diseases that contribute to disability and escalating healthcare...
Eligibility Criteria
Inclusion
- Patients aged 18 years and older with a chronic non-communicable disease
- Signed general informed consent
- Referral to a comprehensive disease-specific rehabilitation program
Exclusion
- Refuted or missing general informed consent for further use of health-related data and samples.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT06516172
Start Date
December 1 2020
End Date
December 1 2030
Last Update
August 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Berner Reha Centre, Centre for Rehabilitation & Sports Medicine, Insel Group
Heiligenschwendi, Canton of Bern, Switzerland, 3625
2
Reha Inselspital, Bern University Hospital, Centre for Rehabilitation & Sports Medicine, Insel Group
Bern, Switzerland, 3010